Halozyme Therapeutics shares owned by Alpha DNA Investment Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Alpha DNA Investment Management
from 13F filings
Historical chart of Alpha DNA Investment Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Alpha DNA Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by Alpha DNA Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $539k | 9.4k | 57.24 |
2024-06-30 | $444k | 8.5k | 52.36 |
2024-03-31 | $272k | 6.7k | 40.68 |
2021-03-31 | $4.0k | 109 | 36.70 |
More positions owned by Alpha DNA Investment Management
View all positions for Alpha DNA Investment Management